International Clinical Trial: A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07464314) titled 'A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults' on March 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: GlaxoSmithKline

Condition: Influenza, Human+COVID-19

Intervention: Biological: Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine Biological: Licensed Seasonal Influenza Vaccine

Recruitment Status: Not recruiting

Phase: Phase 1

Date of Firs...